[
  {
    "ts": null,
    "headline": "Bristol-Myers Squibb Company (BMY) Bernstein 41st Annual Strategic Decisions Conference (Transcript)",
    "summary": "Bristol-Myers Squibb Company (NYSE:BMY) Bernstein 41st Annual Strategic Decisions Conference May 28, 2025 3:30 PM ETCompany ParticipantsChris Boerner -...",
    "url": "https://finnhub.io/api/news?id=5f1c6fb21d8e79bffd4369da6d13fafe7a43871b06bf267a080d4aa729155368",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748458228,
      "headline": "Bristol-Myers Squibb Company (BMY) Bernstein 41st Annual Strategic Decisions Conference (Transcript)",
      "id": 134765927,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "Bristol-Myers Squibb Company (NYSE:BMY) Bernstein 41st Annual Strategic Decisions Conference May 28, 2025 3:30 PM ETCompany ParticipantsChris Boerner -...",
      "url": "https://finnhub.io/api/news?id=5f1c6fb21d8e79bffd4369da6d13fafe7a43871b06bf267a080d4aa729155368"
    }
  },
  {
    "ts": null,
    "headline": "Transcript : Bristol-Myers Squibb Company Presents at Bernstein 41st Annual Strategic Decisions Conference 2025, May-28-2025 03",
    "summary": "Presenter SpeechCourtney Breen Fantastic. Hi, everyone. It's great to have you here for this fireside, the first of our pharmaceutical fireside during the SDC. My name is Courtney Breen. I am the",
    "url": "https://finnhub.io/api/news?id=afe8baf628c2d5ec160bd4c9da4e6be5c09e4c41d706018553be52aff0853dff",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748451929,
      "headline": "Transcript : Bristol-Myers Squibb Company Presents at Bernstein 41st Annual Strategic Decisions Conference 2025, May-28-2025 03",
      "id": 134761293,
      "image": "",
      "related": "BMY",
      "source": "Finnhub",
      "summary": "Presenter SpeechCourtney Breen Fantastic. Hi, everyone. It's great to have you here for this fireside, the first of our pharmaceutical fireside during the SDC. My name is Courtney Breen. I am the",
      "url": "https://finnhub.io/api/news?id=afe8baf628c2d5ec160bd4c9da4e6be5c09e4c41d706018553be52aff0853dff"
    }
  },
  {
    "ts": null,
    "headline": "Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It",
    "summary": "Zacks.com users have recently been watching Bristol Myers (BMY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",
    "url": "https://finnhub.io/api/news?id=1097079bb8f493218ea5e0c36989d99ccb63ca0022de756a1673e8ece61147d2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748437213,
      "headline": "Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It",
      "id": 134755999,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Zacks.com users have recently been watching Bristol Myers (BMY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",
      "url": "https://finnhub.io/api/news?id=1097079bb8f493218ea5e0c36989d99ccb63ca0022de756a1673e8ece61147d2"
    }
  },
  {
    "ts": null,
    "headline": "Bristol Myers Squibb to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference",
    "summary": "PRINCETON, N.J., May 28, 2025--Bristol Myers Squibb to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference",
    "url": "https://finnhub.io/api/news?id=c2cba7adc0459940165a2e26f0a798dc02530079fc547398afeef3aa3bfc4067",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748429940,
      "headline": "Bristol Myers Squibb to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference",
      "id": 134742169,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "PRINCETON, N.J., May 28, 2025--Bristol Myers Squibb to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference",
      "url": "https://finnhub.io/api/news?id=c2cba7adc0459940165a2e26f0a798dc02530079fc547398afeef3aa3bfc4067"
    }
  },
  {
    "ts": null,
    "headline": "Bristol Myers Squibb Receives European Commission Approval for the Subcutaneous Formulation of Opdivo® (nivolumab) Across Multiple Solid Tumor Indications",
    "summary": "PRINCETON, N.J., May 28, 2025--BMS Receives European Commission Approval for the Subcutaneous Formulation of Opdivo (nivolumab) Across Multiple Solid Tumor Indications",
    "url": "https://finnhub.io/api/news?id=1d7df5a1262c3588e254df41f5189f71ac9195ccd50ec84ce5faa6014e47b06f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748429700,
      "headline": "Bristol Myers Squibb Receives European Commission Approval for the Subcutaneous Formulation of Opdivo® (nivolumab) Across Multiple Solid Tumor Indications",
      "id": 134742170,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "PRINCETON, N.J., May 28, 2025--BMS Receives European Commission Approval for the Subcutaneous Formulation of Opdivo (nivolumab) Across Multiple Solid Tumor Indications",
      "url": "https://finnhub.io/api/news?id=1d7df5a1262c3588e254df41f5189f71ac9195ccd50ec84ce5faa6014e47b06f"
    }
  },
  {
    "ts": null,
    "headline": "Orasure Technologies: Multiple Shots To Deliver Value",
    "summary": "Orasure Technologies: Multiple Shots To Deliver Value",
    "url": "https://finnhub.io/api/news?id=bdd7d5b2deaf3cbd71ae35ea92c977e80a3353eaff26836bd58417709c1b98bf",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748427922,
      "headline": "Orasure Technologies: Multiple Shots To Deliver Value",
      "id": 134742544,
      "image": "",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=bdd7d5b2deaf3cbd71ae35ea92c977e80a3353eaff26836bd58417709c1b98bf"
    }
  },
  {
    "ts": null,
    "headline": "Bristol-Myers Squibb's Painful Pullback Has Triggered Richer Dividend Story - Upgrade To Buy",
    "summary": "Bristol-Myers Squibb's Painful Pullback Has Triggered Richer Dividend Story - Upgrade To Buy",
    "url": "https://finnhub.io/api/news?id=0e560613515b9e99656ba60c6cb07e5646c687562dce63eccdba81fb27b6e175",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748426825,
      "headline": "Bristol-Myers Squibb's Painful Pullback Has Triggered Richer Dividend Story - Upgrade To Buy",
      "id": 134742023,
      "image": "",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=0e560613515b9e99656ba60c6cb07e5646c687562dce63eccdba81fb27b6e175"
    }
  },
  {
    "ts": null,
    "headline": "Bristol Myers Squibb Receives European Commission Approval for the Subcutaneous Formulation of Opdivo®? Across Multiple Solid Tumor Indications",
    "summary": "Bristol Myers Squibb announced that the European Commission has approved a new Opdivo®? formulation associated with a new route of administration , a new pharmaceutical form and a new strength ....",
    "url": "https://finnhub.io/api/news?id=bca72f9120c328f27a9e67d720331a0390601b4f90e90fa81f4e970e5b425a1d",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748422310,
      "headline": "Bristol Myers Squibb Receives European Commission Approval for the Subcutaneous Formulation of Opdivo®? Across Multiple Solid Tumor Indications",
      "id": 134741147,
      "image": "",
      "related": "BMY",
      "source": "Finnhub",
      "summary": "Bristol Myers Squibb announced that the European Commission has approved a new Opdivo®? formulation associated with a new route of administration , a new pharmaceutical form and a new strength ....",
      "url": "https://finnhub.io/api/news?id=bca72f9120c328f27a9e67d720331a0390601b4f90e90fa81f4e970e5b425a1d"
    }
  },
  {
    "ts": null,
    "headline": "Bristol Myers: EU green light for Opdivo subcutaneous injection",
    "summary": "Bristol Myers Squibb announces that the European Commission has approved a new formulation of Opdivo , which can now be administered subcutaneously . This version, co-formulated with recombinant human...",
    "url": "https://finnhub.io/api/news?id=c90f99478eee3db2d5ce24db0e21bc9cd3998f392c5ab388098afc340dc0cf57",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748420171,
      "headline": "Bristol Myers: EU green light for Opdivo subcutaneous injection",
      "id": 134740849,
      "image": "",
      "related": "BMY",
      "source": "Finnhub",
      "summary": "Bristol Myers Squibb announces that the European Commission has approved a new formulation of Opdivo , which can now be administered subcutaneously . This version, co-formulated with recombinant human...",
      "url": "https://finnhub.io/api/news?id=c90f99478eee3db2d5ce24db0e21bc9cd3998f392c5ab388098afc340dc0cf57"
    }
  },
  {
    "ts": null,
    "headline": "Bristol Myers Gets European Approval for Subcutaneous Opdivo",
    "summary": "By Colin Kellaher Bristol Myers Squibb has won European approval of a formulation of its blockbuster cancer drug Opdivo that can be injected under the skin. Bristol Myers on Wednesday said...",
    "url": "https://finnhub.io/api/news?id=622f13fd1809c51f52f6dd85fca4339e1c92222a189e7d828cb7383f2dd9ce88",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748418436,
      "headline": "Bristol Myers Gets European Approval for Subcutaneous Opdivo",
      "id": 134740543,
      "image": "",
      "related": "BMY",
      "source": "Finnhub",
      "summary": "By Colin Kellaher Bristol Myers Squibb has won European approval of a formulation of its blockbuster cancer drug Opdivo that can be injected under the skin. Bristol Myers on Wednesday said...",
      "url": "https://finnhub.io/api/news?id=622f13fd1809c51f52f6dd85fca4339e1c92222a189e7d828cb7383f2dd9ce88"
    }
  }
]